Caspofungin Market

Caspofungin Market (Indication - Candidiasis, Thrush; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • Rep Id : TMRGL64311
  • Published On : Apr 2019
  • No. of Pages : 156
  • Category : Pharmaceutical

Section 1 Preface 
            1.1 Report Scope and Market Segmentation 
            1.2 Research Highlights

Section 2 Assumptions and Research Methodology 
            2.1 Assumptions
            2.2 Research Methodology

Section 3 Executive Summary
            3.1 Global Caspofungin Market Snapshot
            3.2 Key Industry Developments

Section 4 Market Overview
            4.1 Caspofungin Market Taxonomy
            4.2 Caspofungin Drug Introduction
            4.3 Global Caspofungin Market Size (US$ Mn) Forecast, 2017–2027
            4.4 Global Caspofungin Market: Market Outlook
            4.5 Rise in incidence of invasive candidiasis across the globe
                  4.5.1.Rise in geriatric population
                  4.5.2.Advantages of echinocandins over other antifungal
                  4.5.3.Restraints
                          4.5.3.1 Availability of Generic Drugs
                          4.5.3.2 Emergence of resistant species
                  4.5.4 Opportunities
                          4.5.4.1 Echinocandins, as first line of therapy in candidiasis
                          4.5.4.2 Expansion of Research and Development in Emerging Markets

Section 5 Key Insights
            5.1 Clinical Trial Pipeline Analysis
            5.2 Disease Prevalence & Incidence Rate globally with key countries
            5.3 Supply Chain Analysis
            5.4 Pricing Analysis by Manufacturers

Section 6 Global Caspofungin Market Analysis, by Indication
            6.1 Key Findings
            6.2 Introduction
            6.3 Market Value Share Analysis, by Indication
            6.4 Market Value Forecast, by Indication, 2017–2027
            6.5 Market Analysis, by Indication, 2017–2027
                  6.5.1 Candidiasis
                  6.5.2 Thrush
            6.6 Market Attractiveness, by Indication 

Section 7 Global Caspofungin Market Analysis, by Distribution Channel
            7.1 Key Findings
            7.2 Introduction
            7.3 Market Value Share Analysis, by Distribution Channel
                  7.5.1. Hospital Pharmacies
                  7.5.2 Retail Pharmacies
                  7.5.3 Online Pharmacies
            7.6 Market Attractiveness, by Distribution Channel 

Section 8 Global Caspofungin Market Analysis, by Region
            8.1 Market Value Share Analysis, by Region
            8.2 Market Forecast, by Region
            8.3 Global Caspofungin Market Attractiveness Analysis, by Region

Section 9 North America Caspofungin Market Analysis
            9.1 Market Overview
            9.2 Market Value Share Analysis, by Indication
            9.3 Caspofungin Market Forecast, by Indication
            9.4 Market Value Share Analysis, by Distribution Channel
            9.5 Caspofungin Market Forecast, by Distribution Channel
            9.6 U.S.
                  9.6.1 Canada
            9.7 Market Attractiveness Analysis
                  9.7.1 By Country
                  9.7.2 By Indication
                  9.7.3 By Distribution Channel

Section 10 Europe Caspofungin Market Analysis
            10.1 Market Overview
            10.2 Market Value Share Analysis, by Indication
            10.3 Caspofungin Market Forecast, by Indication
            10.4 Market Value Share Analysis, by Distribution Channel
            10.5 Caspofungin Market Forecast, by Distribution Channel
            10.6 Market Value Share Analysis, by Country/Sub-region
            10.7 Market Forecast, by Country/Sub-region
                  10.7.1 Germany
                  10.7.2 U.K.
                  10.7.3 France
                  10.7.4 Spain
                  10.7.5 Italy
                  10.7.6 Rest of Europe
            10.8 Market Attractiveness Analysis
                  10.8.1 By Country/Sub-region
                  10.8.2 By Indication
                  10.8.3 By Distribution Channel

Section 11 Asia Pacific Caspofungin Market Analysis
            11.1 Market Overview
            11.2 Market Value Share Analysis, by Indication
            11.3 Caspofungin Market Forecast, by Indication
            11.4 Market Value Share Analysis, by Distribution Channel
            11.5 Caspofungin Market Forecast, by Distribution Channel
            11.6 Market Value Share Analysis, by Country/Sub-region
            11.7 Market Forecast, by Country/Sub-region
                  11.7.1 China
                  11.7.2 Japan
                  11.7.3 India
                  11.7.4 Australia & New Zealand
                  11.7.5 Rest of Asia Pacific
            11.8 Market Attractiveness Analysis
                  11.8.1 By Country/Sub-region
                  11.8.2 By Indication
                  11.8.3 By Distribution Channel

Section 12 Latin America Caspofungin Market Analysis
            12.1 Market Overview
            12.2 Market Value Share Analysis, by Indication
            12.3 Caspofungin Market Forecast, by Indication
            12.4 Market Value Share Analysis, by Distribution Channel
            12.5 Caspofungin Market Forecast, by Distribution Channel
            12.6 Market Value Share Analysis, by Country/Sub-region
            12.7 Market Forecast, by Country/Sub-region
                  12.7.1 Brazil
                  12.7.2 Mexico
                  12.7.3 Rest of Latin America
            12.8 Market Attractiveness Analysis
                  12.8.1 By Country/Sub-region
                  12.8.2 By Indication
                  12.8.3 By Distribution Channel

Section 13 Middle East & Africa (MEA) Caspofungin Market Analysis
            13.1 Market Overview
            13.2 Market Value Share Analysis, by Indication
            13.3 Caspofungin Market Forecast, by Indication
            13.4 Market Value Share Analysis, by Distribution Channel
            13.5 Caspofungin Market Forecast, by Distribution Channel
            13.6 Market Value Share Analysis, by Country/Sub-region
            13.7 Market Forecast, by Country/Sub-region
                  13.7.1 GCC Countries
                  13.7.2 South Africa
                  13.7.3 Israel
                  13.7.4 Rest of MEA
            13.8 Market Attractiveness Analysis
                  13.8.1 By Country/Sub-region
                  13.8.2 By Indication
                  13.8.3 By Distribution Channel

Section 14 Company Profiles
            14.1 Market Player - Competition Matrix (By Tier and Size of companies)
            14.2 Market Share Analysis, by Company, 2017
            14.3 Company Profile
                  14.3.1 Teva Pharmaceutical Industries Ltd.
                           14.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                           14.3.1.2 Financial Overview
                           14.3.1.3 Product Portfolio
                           14.3.1.4 SWOT Analysis
                           14.3.1.5 Strategic Overview
                  14.3.2 Novartis AG
                           14.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)
                           14.3.2.2 Financial Overview
                           14.3.2.2 Product Portfolio
                           14.3.2.3 SWOT Analysis
                           14.3.2.4 Strategic Overview
                  14.3.3 Mylan N.V.
                           14.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)
                           14.3.3.2 Financial Overview
                           14.3.3.3 Product Portfolio
                           14.3.3.4 SWOT Analysis
                           14.3.3.5 Strategic Overview
                  14.3.4 Merck & Co., Inc. 
                           14.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)
                           14.3.4.2 Financial Overview
                           14.3.4.2 Product Portfolio
                           14.3.4.3 SWOT Analysis
                           14.3.4.4 Strategic Overview
                  14.3.5 Fresenius SE & Co. KGaA 
                           14.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)
                           14.3.5.2 Financial Overview
                           14.3.5.2 Product Portfolio
                           14.3.5.3 SWOT Analysis
                           14.3.5.4 Strategic Overview
                  14.3.6 Gland Pharma Limited (Shanghai Fosun Pharmaceutical (Group) Co., Ltd.)
                           14.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)
                           14.3.6.2 Financial Overview
                           14.3.6.3 Product Portfolio
                           14.3.6.4 SWOT Analysis
                           14.3.6.5 Strategic Overview
                  14.3.7 Xellia Pharmaceuticals 
                           14.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)
                           14.3.7.2 Financial Overview
                           14.3.7.3 Product Portfolio
                           14.3.7.4 SWOT Analysis
                           14.3.7.5 Strategic Overview

Table 01: Caspofungin Brands in India and their Prices
Table 02: Caspofungin Brands in Germany and their Prices
Table 03: Pipeline Analysis, by Phase 3 Drugs
Table 04: Country Estimated Burden and Prevalence Rate of Candidiasis 
Table 05: List of Prescription Products
Table 06: List of Prescription Products
Table 07: List of Generic Prescription Products
Table 08: Global Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 09: Global Caspofungin Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 10: Global Caspofungin Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 11: North America Caspofungin Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 12: North America Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 13: North America Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 14: Europe Caspofungin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 15: Europe Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 16: Europe Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 17: Asia Pacific Caspofungin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 18: Asia Pacific Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 19: Asia Pacific Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 20: Latin America Caspofungin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21: Latin America Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 22: Latin America Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 23: Middle East & Africa Caspofungin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 24: Middle East & Africa Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 25: Middle East & Africa Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Figure 01: Global Caspofungin Market Snapshot
Figure 02: Global Caspofungin Market Value (US$ Mn) Forecast, 2019–2027
Figure 03: Market Value Share, by Indication, 2018
Figure 04: Market Value Share, by Distribution Channel, 2018
Figure 05: Market Value Share, by Region, 2018
Figure 06: Global Caspofungin Market Value Share Analysis, by Indication, 2018 and 2027
Figure 07: Global Caspofungin Market Revenue (US$ Mn) Forecast, by Candidiasis, 2019–2027 
Figure 08: Global Caspofungin Market Revenue (US$ Mn) Forecast, by Thrush, 2019–2027
Figure 09: Global Caspofungin Market Attractiveness, by Indication, 2019–2027
Figure 10: Global Caspofungin Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 11: Global Caspofungin Market Revenue (US$ Mn), by Hospital Pharmacies, 2017–2027
Figure 12: Global Caspofungin Market Revenue (US$ Mn), by Retail Pharmacies, 2017–2027
Figure 13: Global Caspofungin Market Revenue (US$ Mn), by Online Pharmacies, 2017–2027
Figure 14: Global Caspofungin Market Attractiveness, by Distribution Channel, 2019–2027
Figure 15: Global Caspofungin Market Value Share, by Region, 2018 and 2027
Figure 16: Global Caspofungin Market Attractiveness, by Region, 2019–2027
Figure 17: North America Caspofungin Market Value (US$ Mn) Forecast, 2019–2027
Figure 18: North America Caspofungin Market Value Share, by Country, 2018 and 2027
Figure 19: North America Caspofungin Market Attractiveness, by Country, 2019–2027
Figure 20: North America Caspofungin Market Value Share Analysis, by Indication, 2018 and 2027
Figure 21: North America Caspofungin Market Attractiveness, by Indication, 2019–2027
Figure 22: North America Caspofungin Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 23: North America Caspofungin Market Attractiveness, by Distribution Channel, 2019–2027
Figure 24: Europe Caspofungin Market Value (US$ Mn) Forecast, 2019–2027
Figure 25: Europe Caspofungin Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 26: Europe Caspofungin Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 27: Europe Caspofungin Market Value Share Analysis, by Indication, 2018 and 2027
Figure 28: Europe Caspofungin Market Attractiveness, by Indication, 2019–2027
Figure 29: Europe Caspofungin Market Value Share Analysis, by Distribution Channel
Figure 30: Europe Caspofungin Market Attractiveness, by Distribution Channel, 2019–2027
Figure 31: Asia Pacific Caspofungin Market Value (US$ Mn) Forecast, 2019–2027
Figure 32: Asia Pacific Caspofungin Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 33: Asia Pacific Caspofungin Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 34: Asia Pacific Caspofungin Market Value Share Analysis, by Indication, 2018 and 2027
Figure 35: Asia Pacific Caspofungin Market Attractiveness, by Indication, 2019–2027
Figure 36: Asia Pacific Caspofungin Market Value Share Analysis, by Distribution Channel, 2018 and 2027 
Figure 37: Asia Pacific Caspofungin Market Attractiveness, by Distribution Channel, 2019–2027
Figure 38: Latin America Caspofungin Market Value (US$ Mn) Forecast, 2019–2027
Figure 39: Latin America Caspofungin Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 40: Latin America Caspofungin Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 41: Latin America Caspofungin Market Value Share Analysis, by Indication, 2018 and 2027
Figure 42: Latin America Caspofungin Market Attractiveness, by Indication, 2019–2027
Figure 43: Latin America Caspofungin Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 44: Latin America Caspofungin Market Attractiveness, by Distribution Channel, 2019–2027
Figure 45: Middle East & Africa Caspofungin Market Value (US$ Mn) Forecast, 2019–2027
Figure 46: Middle East & Africa Caspofungin Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 47: Middle East & Africa Caspofungin Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 48: Middle East & Africa Caspofungin Market Value Share Analysis, by Indication, 2018 and 2027
Figure 49: Middle East & Africa Caspofungin Market Attractiveness, by Indication, 2019–2027
Figure 50: Middle East & Africa Caspofungin Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 51: Middle East & Africa Caspofungin Market Attractiveness, by Distribution Channel, 2019–2027
Figure 52: Teva Pharmaceutical Industries Ltd., Generic Products Revenue (US$ Mn), 2015–2018
Figure 53: Teva Pharmaceutical Industries Ltd., Generic Products Breakdown of Net Sales (%), by Business Segment, 2018
Figure 54 Teva Pharmaceutical Industries Ltd., R&D Expenses (US$ Mn), 2015–2018
Figure 55: Teva Pharmaceutical Industries Ltd. Breakdown of Generic Products Net Sales (%), by Region, 2018
Figure 56: Sandoz Division Revenue (US$ Mn), 2015–2018
Figure 57: Sandoz Division Breakdown of Net Sales (%), by Region, 2018
Figure 58: Novartis AG, R&D Expenses (US$ Mn), 2015–2018
Figure 59: Novartis AG, Breakdown of Net Sales (%), by Business Segment, 2018
Figure 60: Mylan N.V. Revenue (US$ Mn), 2015–2018
Figure 61: Mylan N.V., Breakdown of Net Sales (%), by Region, 2018
Figure 62: Mylan N.V., R&D Expenses (US$ Mn), 2015-2018
Figure 63: Merck & Co., Inc., Revenue (US$ Mn), 2015–2018
Figure 64: Merck & Co., Inc., Breakdown of Net Sales (%), by Region, 2018
Figure 65: Merck & Co., Inc., R&D Expenses (US$ Mn), 2015–2017
Figure 66: Merck & Co., Inc., Breakdown of Net Sales (%), by Business Segment, 2017
Figure 67: Fresenius Kabi AG, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 68: Fresenius Kabi AG, Breakdown of Net Sales, by Region, 2018
Figure 69: Fresenius Kabi AG, R&D Expenses (US$ Mn), 2015–2018
Figure 70: Fresenius Kabi AG, Breakdown of Net Sales, by Product Segment, 2018
Figure 71: Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Revenue (US$ Mn), 2015–2017
Figure 72: Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Breakdown of Net Sales (%), by Business Segment, 2018
Figure 73: Shanghai Fosun Pharmaceutical (Group) Co., Ltd., R&D Expenses (US$ Mn), 2015–2017
Figure 74: Xellia Pharmaceuticals Revenue (US$ Mn), 2015–2018
Figure 75: Xellia Pharmaceuticals, Breakdown of Net Sales (%), by Region, 2018
Figure 76: Xellia Pharmaceuticals, R&D Investment (US$ Mn), 2015–2018
Figure 77: Xellia Pharmaceuticals, Breakdown of Net Sales (%), by Business Segment, 2018

.